See All Slides - tctmd.com

Slides

Presentation TCT 2013

Technology Review and Clinical Results

Presenter: John Webb

October 28, 2013

Presentation TCT 2013

The Hybrid Approach I: The Algorithm and the Registry

Presenter: David Daniels

October 28, 2013

Presentation TCT 2013

Robotic Percutaneous Cardiovascular Intervention: Current Status and Future Directions

Presenter: Giora Weisz

October 28, 2013

Presentation TCT 2013

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

Presenter: Andrew Farb

October 28, 2013

Presentation TCT 2013

Appropriate Tumors, Stages and Locations, Relevant Vascular Anatomy, and Clinical Goals and Expectations

Presenter: Shaun Samuels

October 28, 2013

Presentation TCT 2013

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Presenter: Finn Gustafsson

October 28, 2013

Presentation TCT 2013

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Presenter: Alex Powell

October 28, 2013

Presentation TCT 2013

Didactic(5)

Presenter: Lynne Hinterbuchner

October 28, 2013

Presentation TCT 2013

CTO PCI Justification: Making the Case with Evidence

Presenter: J. Aaron Grantham

October 28, 2013

Presentation TCT 2013

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Presenter: Hans Figulla

October 28, 2013

Advertisement

Slides

Technology Review and Clinical Results

The Hybrid Approach I: The Algorithm and the Registry

Robotic Percutaneous Cardiovascular Intervention: Current Status and Future Directions

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

Appropriate Tumors, Stages and Locations, Relevant Vascular Anatomy, and Clinical Goals and Expectations

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Didactic(5)

CTO PCI Justification: Making the Case with Evidence

Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content